Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight
The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.
Catheter-based treatment linked to major benefits for intermediate-risk PE
New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.
FDA sees promise in voice-based AI model for heart failure
An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.
Software errors lead to major insulin pump recall—manufacturer shares a fix
Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.
Getting vascular surgeons more involved leads to key improvements for PAD patients
Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?

‘Really Not Close’: TAVR Trumps SAVR in Two Trials of Low-risk Patients

Clinical trials presented at ACC.19 flipped the script on TAVR vs. SAVR.

Positive Projections: TAVR/TMVR Market Likely to Double by 2023

The global market for transcatheter treatment of the mitral and aortic valves is expected to increase from $4 billion to $8 billion in the next five years, but barriers exist.

Stop the Bleeding: Hemorrhagic Complications Gain Ground on Ischemia in Treating Patients with Arrhythmia

Atrial fibrillation patients with coronary artery disease pose a delicate balancing act for physicians. A growing awareness of bleeding vs. ischemic risks could soon lead to a steadier therapeutic response.

BioCardia receives clearance for AVANCE steerable catheter introducers

BioCardia’s AVANCE steerable introducer family has received FDA 510(k) clearance, the company announced May 8.

Study reveals patients don’t know much about their heart implants—but they want to

Research presented at the Heart Rhythm Society’s 40th annual scientific sessions in San Francisco May 7 suggests heart patients with implanted electronic devices know less about their therapies than they think they do.

Antiglycemic agent tied to 55 cases of life-threatening gangrene in diabetics

The FDA has tied sodium-glucose cotransporter-2 inhibitors to 55 cases of a life-threatening form of gangrene in the past six years, according to a May 7 report in the Annals of Internal Medicine.

More young people in the US are dying from HF-related CVD

The prevalence of heart failure (HF) in the U.S. is increasing hand-in-hand with rising rates of diabetes and obesity, according to a recent analysis, and HF-related CVD death rates have followed suit—most notably in younger adults.

CVD in pregnancy the leading cause of death among US mothers

Heart disease is now the leading cause of maternal deaths in the U.S., the American College of Obstetricians and Gynecologists (ACOG) reported in early May, prompting the organization to publish a comprehensive guide on pregnancy and CVD.

Clinical

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

Catheter-based treatment linked to major benefits for intermediate-risk PE

FDA sees promise in voice-based AI model for heart failure

Software errors lead to major insulin pump recall—manufacturer shares a fix

Getting vascular surgeons more involved leads to key improvements for PAD patients